Aim of the laboratory is to develop translational molecular medicine studies for novel targeted therapies 





  • Studies on molecular pathology mechanisms, genes, antigens and proteins directly involved in tumour, infectious and inflammatory diseases

  • Development of therapeutic molecules and innovative strategies for drug delivery protocols by electric fields in models of human pathologies

  • Administration of immunomodulatory molecules and systemic delivery of recombinant proteins by plasmid DNA in pre-clinical protocols

  • Identification of biomarkers related to tumour, infectious and inflammatory diseases

  • Validation of devices and new bio-materials to transfer in the clinical practice


Emanuela Signori - MSc, PhD

 eacr new




Felix qui potuit rerum cognoscere causas

Virgilio - Georgiche (II, v. 490)